A-PHP

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcDifferent in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse
3. 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
4. 2026-09-24srcA review of synthetic cathinones emerging in recent years (2019–2022).
5. 2026-09-24srcPsychoactive 'bath salts' intoxication with methylenedioxypyrovalerone
6. 2026-09-24srcEffects of α-pyrrolidino-phenone cathinone stimulants on locomotor behavior in female rats.
7. 2026-09-24srcα-PHP: Acute effects and pharmacokinetic in male and female mice, and clinical data on related intoxications
8. 2026-09-24srcA Strategy to Prioritize Emerging Drugs of Abuse for Analysis: Abuse Liability Testing Using Intracranial Self-Stimulation (ICSS) in Rats and Validation with α-Pyrrolidinohexanophenone (α-PHP)
9. 2026-09-24srcAcute poisoning involving the pyrrolidinophenone-type designer drug 4'-methyl-alpha-pyrrolidinohexanophenone (MPHP)
10. 2026-09-24srcStructure-Activity Relationships for a Recently Controlled Synthetic Cathinone Dopamine Transporter Reuptake Inhibitor: α-Pyrrolidinohexiophenone (α-PHP)
11. 2026-09-24srcIntoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats
12. 2026-09-24srcFetal death associated with the use of 3,4-MDPHP and α-PHP
13. 2026-09-24srcToxicological Investigation of a Case Series Involving the Synthetic Cathinone α-Pyrrolidinohexiophenone (α-PHP) and Identification of Phase I and II Metabolites in Human Urine
14. 2026-09-24srcToxicokinetics of the Synthetic Cathinone α-Pyrrolidinohexanophenone
15. 2026-09-24srcPharmacological characterization of designer cathinones in vitro
16. 2026-09-24srcBath salts, spice, and related designer drugs: the science behind the headlines
17. 2026-09-24srcThe Designer Drug αPHP Affected Cell Proliferation and Triggered Deathly Mechanisms in Murine Neural Stem/Progenitor Cells
18. 2026-09-24srcPyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations
19. 2026-09-24srcEvaluation of Cytotoxic and Mutagenic Effects of the Synthetic Cathinones Mexedrone, α-PVP and α-PHP
20. 2026-09-24srcThe Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
21. 2026-09-24srcα-Pyrrolidinohexanophenone (α-PHP) and α-Pyrrolidinoisohexanophenone (α-PiHP): A Review
22. 2026-09-24srcNovel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling
23. 2026-09-24srcSchedules of Controlled Substances: Placement of alpha-Pyrrolidinohexanophenone in Schedule I (Federal Register 2021-15114)
24. 2026-09-24srcAlpha-PHP - Expert Committee on Drug Dependence Information Repository
25. 2026-09-24srcSubstance Details: alpha-PHP (UNODC Laboratory and Scientific Section)
26. 2026-09-04issueIssued emergency
27. 2026-09-04issueIssued info_card
28. 2026-09-04issueIssued notice
29. 2026-06-04proposal55 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
30. 2026-06-04publicationPublication — backfill
31. 2026-04-28revisionRevision 1
32. 2026-04-28absenceSearched Multiple sources for "alpha-PHP IC50 DAT dopamine transporter specific binding affinity" — no results
33. 2026-04-28absenceSearched PubMed for "tramadol stimulant cathinone interaction fatal toxicity" — no results
34. 2026-04-28absenceSearched ClinicalTrials.gov for "alpha-PHP pyrrolidinohexanophenone" — no results
35. 2026-04-28genGeneration — pipeline-v5 · with 2 morepipeline-v5
36. 2026-04-28rungeneration run

The same entries, as forms: six forms.